Global IP Protection: U.S. “Priority Watch List” Includes Major Suppliers

The U.S. Trade Representative's 2009 Special 301 Report cites a number of countries that serve as major suppliers of pharmaceuticals for failing to provide adequate protection of intellectual property rights